Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/MEDICAMEQ stock hub

NSE/MEDICAMEQ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/MEDICAMEQis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.7B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/MEDICAMEQ

In the news

Latest news · NSE/MEDICAMEQ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E47.4

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC3.4

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/MEDICAMEQ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

INR

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	376
Employees Change	-2%
Employees Change Percent	-0.53
Enterprise value	INR 3.6B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE646B01010
Last refreshed	2026-05-10
Market cap	INR 3.7B
Price	INR 293
Price currency	INR
Rev Per Employee	4,577,061.17x
Sector	Healthcare
Sic	2834
Symbol	nse/MEDICAMEQ
Website	https://www.medicamen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.11%
EV Earnings	46.77x
EV/EBIT	30.43x
EV/EBITDA	19.28x
EV/Sales	2.11x
P/B ratio	1.34x
P/E ratio	47.42x
P/S ratio	2.14x
PE Ratio10 Y	60.62x
PE Ratio3 Y	66.12x
PE Ratio5 Y	64.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.94%
EBITDA Margin	10.95%
Gross margin	50.49%
Gross Profit	INR 868.9M
Gross Profit Growth	3.08%
Gross Profit Growth Q	4%
Gross Profit Growth3 Y	11.82%
Gross Profit Growth5 Y	16.4%
Net Income	INR 77.7M
Net Income Growth	5.34%
Net Income Growth Q	-37.05%
Net Income Growth Years	0%
Net Income Growth3 Y	-17.24%
Net Income Growth5 Y	-6.69%
Pretax Margin	5.47%
Profit Margin	4.51%
Profit Per Employee	INR 206,535
Profitable Years	12
Roa5y	4.23
Roe5y	7.35
ROIC	3.38
Roic5y	7.04

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-31.03%
Cagr3y	-24.72%
Div CAGR3	0%
EPS Growth	-4.02
EPS Growth Q	-47.39
EPS Growth Years	0
EPS Growth3 Y	-18.82
EPS Growth5 Y	-8.18
Revenue Growth	-4.53x
Revenue Growth Q	5.1x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	11.26x
Revenue Growth5 Y	8.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 436.8M
Debt	INR 386.5M
Debt EBITDA	INR 2.05
Debt Equity	INR 0.14
Equity	INR 2.8B
Interest Coverage	3.17
Net Cash	INR 50.3M
Net Cash By Market Cap	INR 1.37
Net Debt EBITDA	INR -0.27
Net Debt Equity	INR -0.02
Tangible Book Value	INR 2.7B
Tangible Book Value Per Share	INR 161
WACC	7.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.75%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 1
Dividend Years	5
Dividend Yield	0.34%
Ex Div Date	2025-09-19
Last Dividend	INR 1
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-31.01%
200-day SMA	339.5
3Y total return	-57.34%
50-day SMA	266
50-day SMA vs 200-day SMA	50under200
All Time High	1,225
All Time High Change	-76.12%
All Time High Date	2022-09-01
All Time Low	217
All Time Low Change	34.82%
All Time Low Date	2026-03-30
ATR	14.23
Beta	0.57
Ch YTD	-19.79
High	299.7
High52	456
High52 Date	2025-05-20
High52ch	-35.85%
Low	283.2
Low52	217
Low52 Date	2026-03-30
Low52ch	34.82%
Ma50ch	9.98%
Price vs 200-day SMA	-13.85%
RSI	67.56
RSI Monthly	41.51
RSI Weekly	43.46
Sharpe ratio	-0.9x
Sortino ratio	-1.22
Total Return	-9.4%
Tr YTD	-19.79
Tr1m	29.67%
Tr1w	13.33%
Tr3m	-16.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 119.4M
Operating Income Growth	-7.94
Operating Income Growth Q	-31.43
Operating Income Growth3 Y	-9.69
Operating Income Growth5 Y	-4.82
Operating margin	6.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,853,646%
Shares Insiders	7.06%
Shares Institutions	0.69%
Shares Qo Q	5.74%
Shares Yo Y	9.75%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	28,090.5x
Bv Per Share	161.1
Ch1m	29.67
Ch1w	13.33
Ch1y	-31.22
Ch3m	-16.32
Ch3y	-57.62
Ch6m	-27.91
Change	-0.59%
Change From Open	-0.81
Close	294.3
Days Gap	0.22
Depreciation Amortization	69,035,750
Dollar Volume	3,457,935
Earnings Date	2026-05-29
EBIT	INR 119.4M
EBITDA	INR 188.4M
EPS	INR 5.84
F Score	2
Fiscal Year End	March
Founded	1,993
Graham Number	174.25948
Graham Upside	-40.42
Income Tax	INR 22M
Is Primary Listing	0
Last Earnings Date	2026-02-13
Last Report Date	2025-12-31
Lynch Fair Value	INR 30.84
Lynch Upside	-89.45
Ma150	332.2
Ma150ch	-11.95%
Ma20	260.6
Ma20ch	12.25%
Next Earnings Date	2026-05-29
Open	294.9
Payment Date	2025-10-26
Position In Range	56.36
Price Date	2026-05-08
Price EBITDA	INR 19.55
Ptbv Ratio	1.34
Relative Volume	0.4x
Revenue	1,720,975,000x
Tax By Revenue	1.28x
Tax Rate	23.39%
Tr6m	-27.91%
Volume	11,822

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/MEDICAMEQ dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.3%

$1.00 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

-9.4%

Next ex-dividend date: 2025-09-19

Performance

NSE/MEDICAMEQ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/MEDICAMEQ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.7%

Share of float held by funds and institutions

Insider ownership

+7.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+9.7%

Negative means the company is buying back shares.

Technical

NSE/MEDICAMEQ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.6

Neutral momentum band

Price vs 200-day MA

-13.8%

50/200-day relationship not available

Beta (5Y)

0.57

Less volatile than the market

Sharpe ratio

-0.90

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/MEDICAMEQ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/MEDICAMEQ stock rating?

nse/MEDICAMEQ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/MEDICAMEQ analysis?

The full report lives at /stocks/nse/MEDICAMEQ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/MEDICAMEQ?

The latest report frames nse/MEDICAMEQ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/MEDICAMEQ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.